MedTrace Logo

Tranexamic Acid in Total Hip Arthroplasty.

NCT02252497 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2016-03-14

No results posted yet for this study

Summary

The purpose of this study is to compare a single preoperative dose of 1g of tranexamic acid (TXA) versus a preoperative dose of 1g of TXA followed by a continuous infusion of 1g over height hours on blood loss.

Conditions

  • Hip Arthroplasty

Interventions

DRUG

Active comparator : Tranexamic Acid (Exacyl)

* 1g Exacyl Intra Venous, just before surgery * Then infusion of 1g of Exacyl over eight hours .

DRUG

Placebo comparator : physiologic serum

* 1g Intra Venous just before surgery * Then infusion of 1g of physiologic serum over eight hours

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Paul ZUFFEREY, MD · CHU SAINT-ETIENNE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02252497 on ClinicalTrials.gov